SR9009 – Solution, 600mg (20mg/mL)

$59.99

SR9009 Solution 600mg (20mg/mL) is a laboratory-grade synthetic Rev-erbα and Rev-erbβ agonist delivered in precise liquid solution form at 20mg/mL concentration, delivering 600mg total. This investigational compound (also known as Stenabolic) functions as a potent agonist of nuclear receptors REV-ERBα and REV-ERBβ with IC50 values of 670 nM and 800 nM respectively, demonstrating significant activity in circadian rhythm regulation and metabolic pathway research for modern scientific investigations in metabolic syndrome modeling. Available for fast, compliant shipping to all 50 U.S. states and throughout European countries.

  • Quality assurance with unique lot-coding and public third-party HPLC/MS lab reports for absolute transparency

  • Formulation completely free of adulterants, excipients, and flow agents to guarantee raw chemical purity

  • Strategic precision over-weighing inside the vessel compensates for natural adhesion loss during laboratory transfer

  • Transit-safe packaging with UV-resistant sealing and tamper-proof closure for international shipment stability

Category:
Description

SR9009 – Solution, 600mg (20mg/mL)

SR9009 represents a premium, laboratory-grade investigational Rev-erbα/β agonist delivered in ultra-pure solution format at 20mg/mL concentration with 600mg total quantity. This high-purity raw chemical material provides exceptional technical value to modern scientific investigations focused on circadian biology, metabolic disorder research, lipid metabolism analysis, and cardiovascular preclinical studies. The liquid solution format at 20mg/mL ensures precise concentration accuracy for analytical testing and in vitro/in vivo modeling applications conducted by qualified investigators studying metabolic pathways and circadian rhythm disruption.

Our global shipping infrastructure ensures seamless delivery to research facilities worldwide. Domestic orders within the United States ship directly from primary U.S. production facilities, ensuring rapid fulfillment across all 50 states. International orders, including all European countries, utilize our dedicated United Kingdom shipping hub to ensure seamless, efficient customs clearance across the UK and continental Europe, minimizing transit delays while maintaining chemical stability throughout shipment.

  • Unique lot-coding on every vessel with public third-party HPLC and mass spectrometry lab reports available for absolute transparency and quality verification

  • Formulation completely free of adulterants, excipients, flow agents, or stabilizers to guarantee unadulterated raw chemical purity for accurate research data

  • Strategic precision over-weighing inside the vessel compensates for natural adhesion loss during laboratory transfer, ensuring investigators receive minimum labeled quantity

  • Packaging engineering utilizes UV-resistant sealing with tamper-proof closure designed specifically for transit safety and structural integrity during international shipment


Technical Specifications & Chemical Profile

Chemical Property Specification Data
Product Name SR9009 (Stenabolic, Rev-erb Agonist)
Common Synonyms SR-9009, SR 9009, Stenabolic, ethyl 3-[[(4-chlorophenyl)methyl-[(5-nitrothiophen-2-yl)methyl]amino]methyl]pyrrolidine-1-carboxylate
CAS Number 1379686-30-2
Molecular Formula C₂₀H₂₄ClN₃O₄S
Molar Mass 437.94 g/mol (474.4 g/mol for HCl salt)
Primary Target Mechanism Rev-erbα/β agonist; IC50 = 670 nM (Rev-erbα), 800 nM (Rev-erbβ)
Physical Form Clear liquid solution (20mg/mL)

Research Applications & Storage Protocols

Rev-erbα/β Agonist Activity & Circadian-Metabolic Pathway Regulation

SR9009 functions as a potent synthetic agonist of the nuclear receptors REV-ERBα and REV-ERBβ, which are core clock components linking circadian rhythms to metabolic regulation. The compound increases the constitutive repression of genes regulated by REV-ERBα/ERBβ with IC50 values of 670 nM and 800 nM respectively, demonstrating dose-dependent increases in REV-ERB-dependent repressor activity. In animal studies, SR9009 activation of Rev-ErbA-α increases exercise capacity by increasing mitochondria counts in skeletal muscle. Chronic low-dose SR9009 treatment mitigates weight gain and insulin resistance caused by circadian disruptions through adipogenesis inhibition. Research applications include circadian rhythm disruption modeling, metabolic syndrome research, lipid metabolism studies, insulin resistance investigations, obesity research, cardiovascular function improvement, and exercise ability/glycolipid metabolism regulation.

Handling & Storage Guidelines

  • Long-Term Storage: Store desiccated at -20°C. Solutions can be stored at -20°C for up to 1 month. Keep in cool, dry place protected from moisture and light. Shelf life up to 12 months.

  • Solubility: Soluble in DMSO (greater than 25 mg/ml) and in Ethanol (up to 20 mg/ml). For in vivo protocols: 5% DMSO, 40% PEG300, 5% Tween-80, 50% Saline.

  • Appearance: Clear solution at 20mg/mL concentration. The parent SR9009 compound is a white to off-white solid/powder when in lyophilized form.

Global Logistics & Order Fulfillment

We proudly support scientific advancement across all 50 U.S. states and throughout Europe. Customers can seamlessly toggle their preferred currency between USD and EUR using the currency switcher located on the left-hand side of our website. All shipments are securely packaged to withstand international transit without compromising structural or chemical stability.

Laboratory Use Only Disclaimer

This material is sold strictly for laboratory research and development use only. It is not approved for human consumption, nor for medical, veterinary, or household applications. All purchases are governed by our standard Terms & Conditions. Please review them carefully before placing your order.

Additional information
pa_feature

Discountinued

pa_form

Liquids

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “SR9009 – Solution, 600mg (20mg/mL)”